经心尖二尖瓣血栓抽吸术（AngioVac 系统）。
Transapical Aspiration of a Mitral Mass With the AngioVac System on a Beating Heart.
机构信息
Division of Cardiac Surgery, Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Division of Cardiac Surgery, Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
出版信息
Ann Thorac Surg. 2020 Nov;110(5):e445-e447. doi: 10.1016/j.athoracsur.2020.04.051. Epub 2020 Jun 3.
The AngioVac System has already proved to be effective and safe in the treatment of thrombotic and endocarditic formations concerning the venous district and the tricuspid valve. We describe an innovative use of the AngioVac System to treat a left-sided heart mass. In a high-surgical-risk patient, we used a micro-invasive transapical access and a modified extracorporeal membrane oxygenation circuit to remove the mass from the mitral bioprosthesis without having to replace it. Further experiences are required to confirm the safety of this technique in high-risk patients.
AngioVac 系统已被证明在治疗涉及静脉区和三尖瓣的血栓和心内膜炎形成方面是有效和安全的。我们描述了一种创新性地使用 AngioVac 系统来治疗左侧心脏肿块的方法。在一位高手术风险的患者中，我们使用微创经心尖入路和改良的体外膜氧合回路从二尖瓣生物瓣上取出肿块，而无需更换。需要进一步的经验来证实这种技术在高风险患者中的安全性。
Zotero 插件